Ipilimumab/nivolumab/vancomycinVarious toxicities and off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1947卷 / 1期

关键词：

D O I：

10.1007/s40278-023-35381-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：241 / 241

相关论文

共 50 条

[21] Ipilimumab/nivolumabColitis and off label use : case report
Reactions Weekly, 2024, 2018 (1) : 252 - 252
[22] Ipilimumab/nivolumab/trametinibGrade 2 folliculitis, lack of efficacy and off-label use : case report
Reactions Weekly, 2023, 1986 (1) : 228 - 228
[23] VancomycinVarious toxicities: case report
Reactions Weekly, 2015, 1549 (1) : 244 - 244
[24] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 2 case report
Reactions Weekly, 2022, 1909 (1) : 304 - 304
[25] VancomycinVarious toxicities: case report
Reactions Weekly, 2009, 1233 (1) : 26 - 27
[26] AntineoplasticsVarious toxicities and off label use: case report
Reactions Weekly, 2023, 1960 (1) : 55 - 55
[27] Baclofen/vancomycinVarious toxicities: case report
Reactions Weekly, 2017, 1646 (1) : 63 - 63
[28] ThalidomideVarious toxicities and off label use: case report
Reactions Weekly, 2022, 1910 (1) : 440 - 440
[29] AntineoplasticsVarious toxicities and off label use: case report
Reactions Weekly, 2020, 1798 (1) : 40 - 40
[30] AntineoplasticsVarious toxicities and off label use: case report
Reactions Weekly, 2022, 1888 (1) : 62 - 62

← 1 2 3 4 5 →